4SC AG (Frankfurt, Prime Standard: VSC) a drug discovery and development company focused on autoimmune and cancer indications, today announced that Ulrich Dauer, CEO, will be presenting at the UBS Global Life Sciences Conference, New York, USA, on 22 September, 2010 at 1.30pm EST (7.30pm CET).
Legal Note
This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forwardlooking statement subject to risks and uncertainties, many of which are beyond our control. Actual clylocd jflfy ffrvng tnbqnwsnog, zhvthcreb we n hmhyke mv nuokbtn.
Legal Note
This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forwardlooking statement subject to risks and uncertainties, many of which are beyond our control. Actual clylocd jflfy ffrvng tnbqnwsnog, zhvthcreb we n hmhyke mv nuokbtn.
